Cervical cancer - Risk Factors and HPV Biology

Causes and Risk Factors for Cervical Cancer Introduction Cervical cancer is a disease with identifiable causes and risk factors. The most important cause is persistent infection with high-risk types of human papillomavirus (HPV). However, HPV infection alone is not sufficient to cause cancer—additional factors increase the likelihood that HPV infection will progress to malignancy. Understanding these causes and risk factors is essential for prevention and screening strategies. Human Papillomavirus: The Primary Cause HPV Infection and Cervical Cancer The overwhelming majority of cervical cancers are caused by infection with specific types of human papillomavirus. HPV types 16 and 18 together cause approximately 75 percent of all cervical cancer cases worldwide. Another 10 percent of cases result from HPV types 31 and 45. Overall, twelve HPV types are classified as high-risk for cancer development: types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. In fact, virtually all cervical cancers contain HPV DNA, highlighting the central role of this virus in cervical cancer development. How High-Risk HPV Causes Cancer When a woman becomes infected with high-risk HPV, the virus integrates its DNA directly into the host cell's genome. Once integrated, the virus produces two particularly important proteins: E6 and E7. These viral proteins work by targeting and destroying two critical tumor-suppressor proteins in the cell: E6 protein degrades p53, a tumor-suppressor protein that normally acts as a "cellular guardian" by detecting damaged DNA and either repairing it or triggering cell death. E7 protein degrades pRb (retinoblastoma protein), another tumor-suppressor protein that normally regulates cell-cycle progression by preventing cells from dividing at inappropriate times. When both p53 and pRb are lost, the cell loses two major safeguards against cancerous transformation. Specifically, the loss of these proteins leads to two dangerous changes: Increased blood vessel growth: Without proper regulation, cells over-express vascular endothelial growth factor (VEGF), which promotes the growth of new blood vessels. This allows developing tumors to receive the blood supply they need to grow. Disrupted cell-cycle regulation: Cells lose the ability to arrest their division cycle when problems are detected, allowing abnormal cells to continue proliferating unchecked. Together, these changes promote the development of cancer. Co-infections and Immunosuppression Women with other concurrent infections or immune system weaknesses face higher cervical cancer risk when infected with HPV. Co-infections with other sexually transmitted infections increase risk. Most notably, HIV infection impairs the immune system's ability to clear HPV naturally, allowing the virus to persist longer and progress to cancer. Similarly, co-infection with trichomoniasis (a parasitic STI) increases cervical cancer risk. Immunosuppression from any cause raises cervical cancer risk. Women taking immunosuppressive medications—such as those prescribed for inflammatory bowel disease—have an elevated chance of developing cervical cancer if they carry high-risk HPV. The unifying principle is clear: a functional immune system is essential for clearing HPV infections before they progress to cancer. Smoking Both active and passive cigarette smoking increase cervical cancer risk. Among women who are infected with HPV, current or former smokers develop invasive cervical cancer at rates two to three times higher than non-smokers. The mechanism involves immune suppression. Smoking weakens immune function, making it harder for the body to clear HPV before it progresses to malignancy. This illustrates an important principle: HPV infection and additional risk factors often work together—smoking alone doesn't cause cervical cancer, but it significantly increases the risk in women already infected with HPV. Hormonal Contraceptives Long-term use of oral contraceptives raises the risk of cervical cancer in women with HPV infection. The exact mechanism is not fully understood, but the effect is well-documented and important for counseling women about contraceptive choices. Pregnancy History Having multiple full-term pregnancies increases cervical cancer risk. The effect is substantial: women who have had seven or more full-term pregnancies have approximately four times the risk of cervical cancer compared with women who have never been pregnant. The biological basis for this association is not entirely clear, but it may relate to hormonal changes during pregnancy, changes to the cervical epithelium, or immune system alterations associated with pregnancy. Sexual and Behavioral Factors Early age at first sexual intercourse and having multiple sexual partners both increase cervical cancer risk. These factors work primarily by increasing the likelihood and duration of HPV exposure. A woman exposed to HPV at younger ages faces a longer window for the infection to establish and progress to cancer. Having more sexual partners increases the probability of encountering high-risk HPV types. <extrainfo> Historical Context The link between HPV and cervical cancer was scientifically established in the 1980s, when papillomavirus DNA was identified in cervical carcinoma samples from diverse geographic regions in 1983. This foundational discovery laid the groundwork for understanding cervical cancer etiology and eventually led to the development of HPV vaccines. Current Prevention Strategies The World Health Organization has established an elimination strategy for cervical cancer that requires: Vaccinating 90% of girls by age 15 Screening 70% of women at ages 35 and 45 Treating 90% of women identified with cervical disease Countries are considered to have eliminated cervical cancer as a public health problem when the incidence falls below 4 cases per 100,000 women and is sustained at that level. </extrainfo>